Stability‐indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC–MS methods
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Bhujanga Rao Nagulancha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM (Deemed to be University), School of Science, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Antiviral Agents, Tandem Mass Spectrometry. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Baloxavir marboxil (BXM) is a polymerase acidic endonuclease inhibitor used as an antiviral drug. A simple, reliable, and robust liquid chromatographic method was developed and validated per International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q2(R1) for estimating the assay and impurities of BXM in drug substance and pharmaceutical formulations. The chromatographic separation was carried out on C 18 (100 × 4.6 mm, 5 μm) with binary solvent delivery system (A:0.1% trifluoroacetic acid in water; B:0.1% trifluoroacetic‐acid in acetonitrile) along with detection wavelength of 260 nm, column temperature of 57°C, flow of 1.2 mL/min and injection volume of 10 μL. All five known impurities and unknown impurities were separated well with resolution >1.7 and were estimated accurately without any interference. Recovered values and regression value were 99.5%–101.2% and R 2 > 0.999, respectively. The recovery and linearity studies covered from 50% to 150% for assay, and quantitation limit, 120% for five BXM impurities. Stability‐indicating property of the HPLC developed method was assessed from the forced degradation studies. The mass spectral data of unknown impurity formed under oxidation stress condition were discussed. The developed method was also successfully utilized for stability sample analysis of drug substance and tablet dosage form.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, GITAM (Deemed to be University), School of Science, Hyderabad, Telangana, India.
- Department of Analytical Research, Graviti Pharmaceutical Pvt Limited, Hyderabad, Telangana, India.
- Department of Chemistry, School of Applied Sciences and Humanities, VIGNAN'S Foundation for Science, Technology & Research, Vadlamudi, Andhra Pradesh, India.
ORCID-Profile: Bhujanga Rao Nagulancha, Narasimha Swamy Lakka, Koteswara Rao Vandavasi
Zitieren
APA
Nagulancha, B. R., Lakka, N. S., & Vandavasi, K. R. (2023). Stability‐indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC–MS methods. Biomedical Chromatography. https://doi.org/10.1002/bmc.5644
Vancouver
Nagulancha BR, Lakka NS, Vandavasi KR. Stability‐indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC–MS methods. Biomedical Chromatography. 2023. doi:10.1002/bmc.5644
BibTeX
@article{Nagulancha2023,
author = {Nagulancha, Bhujanga Rao and Lakka, Narasimha Swamy and Vandavasi, Koteswara Rao},
title = {Stability‐indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC–MS methods},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5644}
}
EUVIMED